Table 5. Prevalence percentages and odds ratios for primary outcome (death or loss-to-follow-up) from the logistic regression analysis.

			Bivariate Analysis	Multivariate Analysis
	Alive and still in follow-up (N = 8615)	Negative outcomes: death, lost to follow up (N = 1798)	OR (95% C.I.)	OR (95% C.I).	p-value
Age: Mean (SD)	35.9 (8.0)	36.0 (8.5)	-	-	0.980
Sex: male	59.1	69.2	1.55 (1.39–1.73)	1.42 (1.21–1.65)	<0.001
Alcoholism: yes	26.0	30.5	1.25 (1.11–1.40)	0.98 (0.84–1.15)	0.804
Literate	90.5	88.1	0.78 (0.66–0.91)	0.68 (0.56–0.83)	<0.001
Prior history of ART	25.1	18.6	0.68 (0.60–0.78)	0.73 (0.58–0.90)	0.004
WHO Stage III/IV at baseline	71.4	87.5	2.81 (2.43–3.26)	2.36 (1.90–2.94)	<0.001
Underweight (BMI <18.5)	44.7	68.3	2.66 (2.37–3.00)	1.97 (1.71–2.26)	<0.001
CD4 at baseline <100	42.9	62.6	2.23 (1.99–2.48)	1.47 (1.29–1.69)	<0.001
Anaemia at baseline	77.2	90.1	2.69 (2.27–3.19)	1.67 (1.36–2.05)	<0.001
Tuberculosis treatment at baseline	34.0	45.5	1.62 (1.46–1.79)	0.90 (0.78–1.04)	0.140
PI base regimen	0.2	0.6	3.26 (1.46–7.28)	4.35 (1.22–15.49)	0.023
Cotrimoxazole preventive therapy at baseline	91.3	93.5	1.37 (1.12–1.67)	1.12 (0.84–1.50)	0.455

OR: Odds ratio; CI: Confidence interval; BMI: Body mass index; SD: Standard deviation; PI: Protease inhibitor; Anaemia: Haemoglobin concentration <12 g/dL in women and <13 g/dL in men.